Ryan Zimmerman
Stock Analyst at BTIG
(4.11)
# 539
Out of 4,918 analysts
180
Total ratings
51.97%
Success rate
12%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Buy | $566 → $571 | $483.12 | +18.19% | 18 | Jul 23, 2025 | |
| RXST RxSight | Downgrades: Neutral | n/a | $7.80 | - | 5 | Jul 9, 2025 | |
| GMED Globus Medical | Downgrades: Neutral | n/a | $52.64 | - | 15 | May 27, 2025 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $35.63 | +85.24% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $243.01 | +11.11% | 19 | Nov 26, 2024 | |
| GKOS Glaukos | Maintains: Buy | $140 → $149 | $86.16 | +72.93% | 10 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $377.79 | +4.29% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $2.28 | +338.60% | 4 | Oct 18, 2024 | |
| ALC Alcon | Maintains: Buy | $104 → $106 | $87.87 | +20.63% | 11 | Oct 14, 2024 | |
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $12.31 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $134 → $126 | $90.62 | +39.04% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $69.85 | +43.16% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $71.73 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $17.76 | +198.42% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.56 | +435.71% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.34 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.16 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.36 | +69.49% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.51 | +33.04% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.67 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $59 → $52 | $20.41 | +154.78% | 7 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.77 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $9.65 | +190.16% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $154.30 | +29.62% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $284.91 | +22.85% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $127.29 | +2.13% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $49.96 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $89.34 | +43.27% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.66 | +18.48% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $67.16 | +35.50% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $18.53 | +126.66% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $6.82 | +669.79% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.67 | - | 3 | Apr 2, 2020 |
Intuitive Surgical
Jul 23, 2025
Maintains: Buy
Price Target: $566 → $571
Current: $483.12
Upside: +18.19%
RxSight
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.80
Upside: -
Globus Medical
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $52.64
Upside: -
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $35.63
Upside: +85.24%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $243.01
Upside: +11.11%
Glaukos
Nov 26, 2024
Maintains: Buy
Price Target: $140 → $149
Current: $86.16
Upside: +72.93%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $377.79
Upside: +4.29%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $2.28
Upside: +338.60%
Alcon
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $87.87
Upside: +20.63%
Integra LifeSciences Holdings
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $12.31
Upside: -
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $90.62
Upside: +39.04%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $69.85
Upside: +43.16%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $71.73
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $17.76
Upside: +198.42%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.56
Upside: +435.71%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.34
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.16
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $2.36
Upside: +69.49%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $4.51
Upside: +33.04%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $8.67
Upside: -
Oct 4, 2023
Maintains: Buy
Price Target: $59 → $52
Current: $20.41
Upside: +154.78%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $10.77
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $9.65
Upside: +190.16%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $154.30
Upside: +29.62%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $284.91
Upside: +22.85%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $127.29
Upside: +2.13%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $49.96
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $89.34
Upside: +43.27%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $12.66
Upside: +18.48%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $67.16
Upside: +35.50%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $18.53
Upside: +126.66%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $6.82
Upside: +669.79%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $12.67
Upside: -